Therapeutics

Immunotherapy (active)

  • Study completed / Planned end date
  • Planned end date unavailable
  • Study aborted
Immunotherapy (active) 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
AADvac-1
Phase 1
AN-1792
Phase 2
Affitope AD02
Phase 2
CAD106
Phase 2
Vanutide cridificar
Phase 2